Condition: Osteoarthritis · Sponsor: VivaTech International, Inc.
This is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the shoulder. Follow-up will consist of a larger sample including 4,000 patients.
This description comes directly from the study's public registry record.
Scott M Herkes, MBA · 855-984-8287 · scott.herkes@gmail.com
Michael P Hutchinson, DVM · 412-503-3788 · drmike@vivatechusa.com
Always discuss trial participation with your own doctor first.
| VivaTech International, Inc. | Grove City, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02844738